← All organizations

Highest phase reached
Phase 3
First clinical trial
Jan 1, 2006First marketed drug
Jun 21, 2011First NDA
Jun 21, 2011Last known activity
Jan 31, 2020
Acquired by Castle Creek Pharmaceuticals on Sep 12, 2019
Timeline
1990s
- Jun 1, 1994
Fibrocell Technologies, Inc.— Founded
2010s
- Jun 21, 2011
azficel-T— NDA Organization
- Sep 12, 2019
Castle Creek Pharmaceuticals— Acquired By
Drugs by trial phase (4 distinct, 11 trials)
Indications
Marketed drugs (1)
Recent trials (11)
- NCT04213261Lead sponsorPhase 3Jan 31, 2020
- NCT03740724Lead sponsorPhase 1/Phase 2Mar 31, 2019
- NCT02810951Lead sponsorPhase 1/Phase 2Jul 1, 2016
- NCT02120781Lead sponsorPhase 2Mar 1, 2014
- NCT01858753Lead sponsorPhase 2May 1, 2013
- NCT00620737Lead sponsorPhase 2Feb 1, 2008
- NCT00642642Lead sponsorPhase 2/Phase 3Nov 1, 2007
- NCT00654654Lead sponsorPhase 2Mar 1, 2007
- NCT00655356Lead sponsorPhase 3Nov 1, 2006
- NCT00649428Lead sponsorPhase 3Oct 1, 2006
- NCT00655889Lead sponsorPhase 2Jan 1, 2006
Details
- Founded
- Exton, PA, US Jun 1, 1994
- First NDA
- Jun 21, 2011
- Last known activity
- Jan 31, 2020